The biology of pneumococcal infection

Pediatric Research

Volumn 42, Issue 3, 1997, Pages 253-258

  Tuomanen, Elaine I ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030838094     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199709000-00001     Document Type: Review

References (46)

1. Watson D, Musher D, Jacobmson J, Verhoef J 1993 A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis 17:913-924
2. Tuomanen E, Austrian R, Masure H 1995 The pathogenesis of pneumococcal infection. N Engl J Med 332:1280-1284
3. Cundell D, Masure H, Tuomanen E 1995 The molecular basis of pneumococcal infection: an hypothesis. Clin Infect Dis 21:S204-212
4. Cundell D, Tuomanen E 1994 Receptor specificity of adherence of Streptococcus pneumoniae to human type II pneumocytes and vascular endothelial cells in vitro. Microb Pathog 17:361-374
5. Hamburger M, Robertson O 1940 Studies of the pathogenesis of experimental pneumococcus pneumonia in the dog. J Exp Med 72:261-274
6. Cundell D, Gerard N, Gerard C, Idanpaan-Heikkila I, Tuomanen E 1995 Streptococcus pneumoniae anchors to activated eukaryotic cells by the receptor for platelet activating factor. Nature 377:435-438
7. Geelen S, Bhattacharyya C, Tuomanen E 1993 Cell wall mediates pneumococcal attachment and cytopathology to human endothelial cells. Infect Immun 61:1538-1543
8. Tuomanen E, Masure R 1997 The molecular and cellular basis of pneumococcal infection. Microbial Drug Resistance 3: (in press)
9. Haverstein L, Coomaraswamy G, Morrison D 1995 An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc Natl Acad Sci USA 92:11140-11144
10. Weiser J, Austrian R, Sreenivasan P, Masure H 1994 Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 62:2582-2589
11. Saluga S, Weiser J 1995 The genetic basis of colonial opacity in Streptococcus pneumoniae: evidence for the effect of box elements on phenotypic variation. Mol Microbiol 2:215-227
12. Cundell D, Weiser J, Shen J, Young A, Tuomanen E 1995 Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun 63:757-761
13. Cundell D, Pearce B, Sandros J, Naughton A, Masure H 1995 Peptide permeases from Streptococcus pneumoniae affect adherence to eucaryotic cells. Infect Immun 63:2493-2498
14. Sampson J, O'Connor R, Stinson A, Tharpe J, Russell H 1994 Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins. Infect Immun 62:319-324
15. Talbot U, Paton A, Paton J 1996 Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect Immun 64:3772-3777
16. Cauwels A, Charpentier E, Tuomanen E 1997 Multifocal defects in pneumococcal physiology caused by disruption of the ActH-ActR signal transduction system. Mol Microbiol (in press)
17. Cheng Q, Campbell E, Naughton A, Johnson S, Masure H 1997 The com locus controls genetic transformation in Streptococcus pneumoniae. Mol Microbiol 23:683-692
18. Guenzi R, Hakenbeck R 1995 Genetic competence and susceptibility to β-lactam antibiotics in Streptococcus pneumoniae R6 are linked via a signal-transducing system cia. Dev Biol Stand 85:125-128
19. Ronda C, Garcia J, Garcia E, Sanchez-Puelles J, Lopez R 1987 Biological role of the pneumococcal amidase: cloning of the lytA gene. Eur J Biochem 164:621-624
20. McDaniel LS, Sheffield JS, Swiatlo E, Yother J, Crain MJ, Briles DE 1992 Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae. Microb Pathog 13:261-269
21. Rosenow C, Ryan P, Weiser J, Johnson S, Fontan P, Ortqvist A, Masure H 1997 Contribution of a novel choline binding protein to adherence, colonization, and immunogenicity of Streptococcus pneumoniae. Infect Immun (in press)
22. Zaitseva F, Campbell E, Masure H 1996 Surface localization and cell signalling by activator, the competence inducing protein of Streptococcus pneumoniae is dependent on phosphorylcholine, a component of the cell wall. Proceedings of the American Society of Microbiology, ASM Press, Washington, DC, p 502
23. Tomasz A 1967 Choline in the cell wall of a bacterium: novel type of polymer-linked choline in pneumococcus. Science 157:694-697
24. Deutsch J, Salman M, Rottem S 1995 An unusual polar lipid from the cell membrane of Mycoplasma fermentans. Eur J Biochem 227:897-902
25. Weiser J, Shchepetov M, Chong S 1997 Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect Immun 65:943-950
26. Tuomanen EI, Tomasz A, Hengstler B, Zak O 1985 The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis 151:535-540
27. Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A 1985 The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 151:859-868
28. Tuomanen E, Rich R, Zak O 1987 Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis 135:869-874
29. Ripley-Petzoldt ML, Giebink GS, Juhn SK, Aeppli D, Tomasz A, Tuomanen E 1988 The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. J Infect Dis 157:245-255
30. Spellerberg B, Prasad S, Cabellos C, Burroughs M, Cahill P, Tuomanen E 1995 Penetration of the blood brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides. J Exp Med 182:1037-1044
31. Tuomanen E, Pollack H, Parkinson A, Davidson M, Facklam R, Rich R, Zak O 1988 Microbiological and clinical significance of a new property of defective lysis in clinical strains of pneumococci. J Infect Dis 158:36-43
32. Tomasz A, Saukkonen K 1989 The nature of cell wall-derived inflammatory components of pnemococci. Pediatr Infect Dis J 8:902-903
33. Geelen S, Bhattacharyya C, Tuomanen E 1992 Induction of procoagulant activity on human endothelial cells by Streptococcus pneumoniae. Infect Immun 60:4179-4183
34. Tuomanen E, Sande S 1989 Inhibition of the binding of penicillin to the pneumococcal penicillin binding proteisn (PBPs) by exogenous cell wall peptides. J Gen Microbiol 135:639-642
35. Riesenfeld-Orn J, Wolpe S, Garcia-Bustos JF, Hoffman MK, Tuomanen E 1989 Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun 57:1890-1893.
36. Henmann D, Barras C, Severin A, Glauser M, Tomasz A 1994 Gram positive cell walls stimulate synthesis of tumor necrosis factor α and interleukin-6 by human monocytes. Infect Immun 62:2715-2721
37. Cabellos C, MacIntyre DE, Forrest M, Burroughs M, Prasad S, Tuomanen E 1992 Differing roles of platelet-activating factor during inflammation of the lung and subarachnoid space. J Clin Invest. 90:612-618
38. Winkelstein J, Tomasz A 1978 Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol 120:174-178
39. Pugin J, Heumann D, Tomasz A, Kravchenki V, Akamatsu Y, Nishijima M, Lauser M, Tobias P, Ulevitch R 1994 CD14 is a pattern recognition receptor. Immunity 1:509-516
40. Pfeffer K, Matsuyama T, Kundig T, Mak T 1993 Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenese infection. Cell 73:457-467
41. Sha W, Liou H, Tuomanen E, Baltimore D 1995 Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330
42. Tan T, Smith C, Hawkins E, Mason E, Kaplan S 1995 Hematogenous bacterial meningitis in an ICAM-1 deficient infant mouse model. J Infect Dis 171:342-349
43. Idanpaan-Heikkila I, Simon P, Cahill C, Sokol K, Tuomanen E 1997 Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. J Infect Dis (in press)
44. Tuomanen E, Hengstler B, Rich R, Bray M, Zak O, Tomasz A 1987 Nonsteroidal anti-inflammatory agents in the therapy of experimental pneumococcal meningitis. J Infect Dis 155:985-990
45. Tuomanen E, Saukkonen K, Sande S, Cioffe C, Wright SD 1989 Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 170:959-969
46. Lebel MH, Freij BJ, Syrogiannopoulos GA, McCracken GS 1988 Dexamethasone therapy for bacterial meningitis. N Engl J Med 15:964-971